Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
UNC Lineberger Comprehensive Cancer Center
Eli Lilly and Company
NRG Oncology
Wake Forest University Health Sciences
University of Chicago
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Pittsburgh
University of Chicago
Icahn School of Medicine at Mount Sinai
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
The First Affiliated Hospital of Guangzhou Medical University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
University of Kentucky
University of Kentucky
Wuhan University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Celgene
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Daiichi Sankyo
Celgene
ChineseAMS
First People's Hospital of Hangzhou
Pfizer
Stanford University
Eli Lilly and Company